RESUMEN

PURPOSE: Sleep difficulties are common in patients with multiple sclerosis (MS), which may increase feelings of fatigue, negatively interfere with daily activities, and consequently reduce their quality of life. Studies examining the effects of sleep-targeted interventions in MS are currently limited in the literature. Therefore, we aim to assess the effects of occupational therapy interventions on sleep quality, fatigue, and quality of life in patients with MS. PATIENTS AND METHODS: In a single-blind, randomized, controlled trial, which occurred between April 2018 and March 2019 in Tehran, Iran, 20 eligible patients with MS were assessed using the Pittsburgh Sleep Quality Index (PSQI), Fatigue Impact Scale (FIS), Fatigue Severity Scale (FSS), and Short-Form Health Survey (SF-36). Patients were allocated randomly into the two following groups: patients receiving care-as-usual for MS (CAU) and patients receiving care-as-usual plus intervention (CAU + intervention). Both intervention groups underwent 2-3 sessions per week lasting 30-45 minutes for 8 weeks and received follow-up assessments. Data were analyzed using independent sample t-tests and Mann-Whitney U tests using SPSS (16 ver.) statistical software. RESULTS: In the intervention group, sleep quality improved significantly across all items (p<0.001, effect size = 0.60) except for sleep efficiency and the use of sleep medications. FSS and FIS in the sleep intervention group were significantly reduced (p<0.001, effect size = 0.76 and p<0.001, effect size = 0.82, respectively). The quality of life in the intervention group improved significantly (p<0.004, effect size = 0.51-0.76) with the exception of the social functioning subgroup. CONCLUSION: Although this is the result of a pilot study and more patients should be added, this intervention program demonstrates improvement in sleep quality and quality of life while decreasing fatigue in patients with MS. Adjunction of this program, if results are similar with more patients, to routine occupational therapy (OT) interventions can help improve the rehabilitation program of MS patients.

RESUMEN

PURPOSE: In Iran, psychotherapy is regarded as an effective treatment for psychiatric disorders. However, no previous research has identified the key elements of psychotherapy that may be specific to Iranian society. The current study was conducted in an attempt to identify these elements. METHODS: A mixed-method modified Delphi approach was used, taking place over several stages during 2017-2018. The first stage involved interviewing 12 experts in psychotherapy to identify key elements of psychotherapy in Iran by thematic analysis. Then, successive Delphi rounds were conducted to obtain consensus (75% agreement) from 70 psychotherapy experts on these key elements. RESULTS: Key elements of psychotherapy were grouped into the following themes: (1) systematic education/training; (2) psychotherapist competency; (3) psychotherapy reflective of Iranian societal needs; and (4) the substrate (scientific/ethical principles) of psychotherapy. Consensus was reached during two Delphi rounds. In Delphi round 1, 52.8% of the statements reached consensus, and all remaining statements reached consensus in round 2. CONCLUSIONS: The key elements of psychotherapy in Iran are a set of conditions for the education and training of competent psychotherapists who can perform psychiatric interventions appropriate to Iranian society under supervised rules. These should serve as a framework for improving the current delivery of psychotherapy in Iran.

Asunto(s)

RESUMEN

INTRODUCTION: Paradoxical insomnia (PARA-I) is a clinically challenging condition to diagnose and treat. Previous findings suggest that personality profiles of patients with PARA-I may be different from other subtypes of insomnia. Therefore, investigation of these profiles can be helpful in the clinical management of these patients. OBJECTIVE: The current study compares personality profiles of individuals with paradoxical insomnia (PARA-I), psycho-physiological insomnia (PSY-I), and normal sleepers (NS). MATERIAL AND METHODS: A cross-sectional case-control study was conducted in the Sleep Disorders Research Center of Kermanshah University of Medical Sciences, Kermanshah, Iran between 2015 and 2017. Patients with PARA-I (n=20), PSY-I (n=20), and NS (n=60) were matched for age, gender, education, and history of mental and/or physical illness and completed the Minnesota Multiphasic Personality Inventory (MMPI) short form. One-way analysis of variance (ANOVA) and the Kruskal-Wallis test were used to compare subscale means across groups. RESULTS: With the exception of the schizophrenia scale (P =.059), significant differences were found in all subscales of the insomnia groups compared to the NS group (P=.001). Compared to the NS group, patients with PARA-I showed significant differences in the hysteria and hypomania subscales (P<.05) and patients with PSY-I showed significant differences in the hysteria, hypochondriasis, and psychopathic subscales (P=.001). No significant differences were found between the PARA-I and PSY-I groups on any subscale. CONCLUSION: This study demonstrates that significant differences in the personality profiles on the MMPI exist between PARA-I and PSY-I patients compared to NS. These findings should inform the diagnosis and future treatment approaches for insomnia.